ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Dec 15, 2020 | Option Exercise | $93.53 | 40 | 3,741 | 63,851 | Dec 18, 2020, 05:06 PM |
ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Dec 16, 2020 | Option Exercise | $157.96 | 21,395 | 3,379,554 | 67,072 | Dec 18, 2020, 05:06 PM |
ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Jun 08, 2020 | Option Exercise | $114.61 | 2,784 | 319,074 | 44,529 | Jun 09, 2020, 04:59 PM |
ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Dec 15, 2019 | Option Exercise | $93.86 | 38 | 3,567 | 47,313 | Mar 03, 2020, 06:26 PM |
ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Mar 02, 2020 | Option Exercise | $90.54 | 1,396 | 126,394 | 47,275 | Mar 03, 2020, 06:26 PM |
ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Jun 07, 2019 | Option Exercise | $118.61 | 2,786 | 330,447 | 37,791 | Jun 11, 2019, 06:39 PM |
ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Dec 15, 2018 | Option Exercise | $93.01 | 34 | 3,162 | 31,149 | Mar 04, 2019, 05:42 PM |
ALXN | | ALEXION PHARMACEUTICALS, INC. | ORLOFF JOHN J | EVP, Research & Development | Feb 28, 2019 | Option Exercise | $132.92 | 675 | 89,721 | 31,115 | Mar 04, 2019, 05:42 PM |
ALXN | | ALEXION PHARMACEUTICALS INC | ORLOFF JOHN J | EVP, Research & Development | Jun 08, 2018 | Sale | $118.53 | 2,115 | 250,691 | 31,790 | Jun 12, 2018, 04:51 PM |
BXLT | | Baxalta Inc | ORLOFF JOHN J | EVP and President, R&D | Mar 03, 2016 | Option Exercise | $39.30 | 1,408 | 55,334 | 96,009 | Mar 07, 2016, 06:18 PM |